Feeling hungry on Wegovy: what it means and what to do

It's the day before your next injection and hunger is back

Picture this: it's been five or six days since your last Wegovy pen. The nausea from earlier in the week has settled, but so has the fullness you were counting on. You're thinking about food more than you'd like to be. This isn't a sign the medicine has stopped working, it reflects the pharmacology. Semaglutide has a half-life of roughly a week, which means blood levels are at their lowest in the day or two before your next injection. That natural trough can bring appetite back, mildly or noticeably, depending on your dose and your individual response.

The pattern tends to improve as your dose increases. At 0.25 mg and 0.5 mg, many people describe the effect as subtle at best. By the time a prescriber has titrated toward the 1.7 mg or 2.4 mg maintenance range, the appetite suppression across the week is usually more consistent. If you're still on an early dose and feeling hungry most days, that's often expected, the titration schedule exists precisely to build toward a dose that works for you. Understanding why hunger persists at different stages of Wegovy treatment can help you track whether what you're experiencing fits the normal pattern or warrants a call to your clinical team.

One quick habit worth building: check the day of the week you inject, then mentally note how you feel on days five and six. If you find you are not hungry on Wegovy during certain parts of the week but appetite returns reliably on days five and six before settling after your next dose, you've identified a trough response rather than treatment failure. That's useful information for your prescriber too.

What you're eating may be working against the medicine

Wegovy slows gastric emptying, which is part of how it creates fullness. But that mechanism relies on there being something worth slowing in the first place. Highly processed foods (think white bread, sugary cereals, rice cakes) digest quickly regardless of how slowly your stomach is moving them along. You can end up hungry again within an hour or two despite the medicine doing its job.

Protein is the nutrient that most reliably extends the feeling of fullness on a GLP-1 medicine. It takes longer to digest, it stimulates additional satiety signals, and it helps preserve muscle tissue when you're eating less overall. Fibre plays a similar role: it slows digestion further and adds physical bulk to meals. Neither is a workaround for a medicine that isn't working, they're the foods the medicine works best with. Practical guidance on building meals that support Wegovy covers this in detail, including portion sizes and meal timing.

The NHS notes that Wegovy is intended to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone treatment, you can read the NHS medicines page for semaglutide for a patient-level overview. The diet component isn't a disclaimer; it's the mechanism.

When still feeling hungry might mean something needs to change

There's a version of hunger on Wegovy that is simply normal, the starter dose, the pre-injection trough, the first few weeks before the medicine settles. Then there's a version that suggests something worth reviewing. If you're at a stable maintenance dose and feeling as hungry as you did before starting treatment, or if your appetite has gradually crept back over several weeks, those are patterns your prescriber needs to know about.

Some people find their response to semaglutide is genuinely lower than average. Others find that stress, poor sleep or illness temporarily overrides appetite suppression, the stress hormone cortisol is a potent hunger driver. Occasionally, hunger that feels different from baseline (urgent, difficult to ignore, accompanied by other symptoms) should be assessed medically rather than managed with food choices alone.

People who feel consistently hungry on a maintenance dose of Wegovy sometimes ask whether switching medicines is an option. That's a clinical conversation, but it's a legitimate one: NICE's appraisal of tirzepatide (Mounjaro) and the SURMOUNT-1 trial published in the New England Journal of Medicine showed greater average weight loss with tirzepatide than semaglutide at comparable timepoints in a head-to-head study. Switching isn't always the answer, and it isn't always appropriate, but the option exists.

What's different if hunger suddenly gets worse

A specific scenario that needs a different kind of attention: you were doing well, appetite was controlled, and then hunger intensified suddenly or came alongside new symptoms. In most cases this reflects a life change, a period of unusual stress, disrupted sleep, stopping a complementary behaviour like regular exercise. But occasionally a sudden change in how your body responds to Wegovy can be worth flagging.

If increased hunger comes with significant stomach pain, nausea beyond your usual adjustment symptoms, or anything that feels physically wrong rather than just appetite-related, contact a healthcare professional. Wegovy's most important side effects to recognise are gastrointestinal; the MHRA's Yellow Card scheme exists for patients to report unexpected effects directly. For those experiencing a specific pattern of increased hunger after a period of stability, that page covers what might have shifted and what to do next.

Private treatment costs vary by dose and provider; if you're weighing the ongoing investment, a clear picture of what's included is worth having before you decide. You can compare what Wegovy costs through different routes and what those prices typically do and don't include. And if you haven't yet started treatment but you're researching what to expect, our prescribers are ready to review your situation properly, no algorithm, just a clinician.